What Has Been the Growth of the Hyperimmune Globulins Market So Far?
The hyperimmune globulins market has seen considerable growth due to a variety of factors.
• The hyperimmune globulins market has seen strong growth in recent years. It is projected to rise from $1.91 billion in 2024 to $2.06 billion in 2025, with a CAGR of 7.8%.
This growth can be traced to increased government support and rising healthcare expenditures.
How Will the Hyperimmune Globulins Market?
The hyperimmune globulins market is expected to maintain its strong growth trajectory in upcoming years.
• The hyperimmune globulins market is expected to grow to $2.76 billion by 2029, at a CAGR of 7.6%.
Growth is supported by rising infectious diseases, increased awareness of hyperimmune globulin benefits, higher immunoglobulin demand, and the prevalence of alpha-1 antitrypsin deficiency and immune deficiencies. Key trends include technological innovations, increased research and development investments, rising demand for passive immunity treatments, advancements in plasma-derived therapies, and progress in manufacturing technologies.
Which Factors Are Boosting Growth In The Hyperimmune Globulins Market?
Government-led healthcare research and development initiatives are expected to propel the hyperimmune globulins market. These initiatives aim to address emerging health challenges and promote the development of new medical solutions. For example, in 2022, the UK government announced £260 million in funding to support healthcare research and manufacturing, boosting the development of treatments like hyperimmune globulins. As a result, government support is driving the growth of the hyperimmune globulins market.
What Key Areas Define The Segmentation Of The Global Hyperimmune Globulins Market?
The hyperimmune globulins market covered in this report is segmented –
1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types
2) By Route Of Administration: Intramuscular, Intravenous
3) By Application: Government Institution, Private Sector, Other Applications
Subsegments:
1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin
2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)
3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)
4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection
5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients
6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions
7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins
Pre-Book The Hyperimmune Globulins Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Hyperimmune Globulins Market?
Major companies operating in the hyperimmune globulins market are:
• F. Hoffmann-La Roche AG
• Bayer AG
• Takeda Pharmaceutical Company Limited
• Baxter International Inc.
• CSL Ltd.
• Fresenius Kabi AG
• Grifols SA
• Octapharma AG
• Shanghai RAAS Blood Products Co. Ltd.
• Emergent BioSolutions Inc.
• Kedrion Biopharma Inc.
• LFB SA
• Hualan Biological Engineering Inc.
• FFF Enterprises Inc.
• Taibang Biologic Group
• Bio Products Laboratory (BPL) Ltd.
• ADMA Biologics
• Cangene Corporation
• Kamada Ltd.
• Saol Therapeutics Inc.
• Omrix Biopharmaceuticals Ltd.
• Shire
• Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.
• BioCare Inc.
What Is The Most Dominant Region In The Hyperimmune Globulins Market?
North America was the largest region in the hyperimmune globulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
